SV40 and the pathogenesis of mesothelioma.
暂无分享,去创建一个
H. Pass | M. Carbone | M. Bocchetta | A. Powers | P. Rizzo | R. Foddis | E. Stekala | Paola Rizzo | Michele Carbone | Harvey I. Pass | Amy Powers | Rudy Foddis | Elizabeth Stekala
[1] Caitlin Smith. Atherosclerosis groups bid for fresh funds , 2002, Nature medicine.
[2] R. Puntoni,et al. Simian virus‐40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma , 2000, Genes, chromosomes & cancer.
[3] H. Pass,et al. Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. Klein. Simian virus 40 and the human mesothelium. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Butel,et al. Response: More About: Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease. , 2000, Journal of the National Cancer Institute.
[6] I. Wistuba,et al. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations , 2000, Journal of cellular biochemistry.
[7] J. Butel,et al. Evidence of SV40 infections in hospitalized children. , 1999, Human pathology.
[8] H. Heylen,et al. Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma. , 1999, The European respiratory journal.
[9] H. Pass,et al. Simian virus 40 (SV40)–like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40‐contaminated polio vaccines , 1999, Molecular carcinogenesis.
[10] Q. Tao,et al. DNA methylation and the Epstein-Barr virus. , 1999, Seminars in cancer biology.
[11] H. Pass,et al. New molecular and epidemiological issues in mesothelioma: Role of SV40 , 1999, Journal of cellular physiology.
[12] R. Robledo,et al. Cellular and molecular mechanisms of asbestos‐induced fibrosis , 1999, Journal of cellular physiology.
[13] T. Bayer,et al. Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. , 1999, Cancer research.
[14] Y. Yonekawa,et al. Identification in Human Brain Tumors of DNA Sequences Specific for SV40 Large T Antigen , 1999, Brain pathology.
[15] G. Rosenthal,et al. Asbestos Toxicity: An Immunologic Perspective , 1999, Reviews on environmental health.
[16] Carl W. Miller,et al. Integration of SV40 in human osteosarcoma DNA , 1998, Oncogene.
[17] V. Rusch,et al. A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. , 1998, Cancer research.
[18] J. Butel,et al. Natural Isolates of Simian Virus 40 from Immunocompromised Monkeys Display Extensive Genetic Heterogeneity: New Implications for Polyomavirus Disease , 1998, Journal of Virology.
[19] S. Steinberg,et al. Simian virus-40 large-T antigen binds p53 in human mesotheliomas , 1997, Nature Medicine.
[20] M. Simon,et al. A malignant astrocytoma containing simian virus 40 DNA in a macaque infected with simian immunodeficiency virus , 1997, Journal of medical primatology.
[21] L. Hennighausen,et al. Time-Sensitive Reversal of Hyperplasia in Transgenic Mice Expressing SV40 T Antigen , 1996, Science.
[22] H. Pass,et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. , 1994, Oncogene.
[23] R. Reddel,et al. SV40-induced immortalization of human cells. , 1994, Critical reviews in oncogenesis.
[24] C. Cicala,et al. SV40 induces mesotheliomas in hamsters. , 1993, The American journal of pathology.
[25] C. Cicala,et al. SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo. , 1992, Virology.
[26] B. Lanphear,et al. Latent period for malignant mesothelioma of occupational origin. , 1992, Journal of occupational medicine. : official publication of the Industrial Medical Association.
[27] M. Simon,et al. Simian virus 40-induced disease in rhesus monkeys with simian acquired immunodeficiency syndrome. , 1992, The American journal of pathology.
[28] C. Nicolini,et al. Molecular Basis of Human Cancer , 1991, NATO ASI Series.
[29] F. O'Neill,et al. Amplification of papovavirus defectives during serial low multiplicity infections. , 1981, Virology.
[30] K. Shah,et al. Simian virus 40-associated fatal interstitial pneumonia and renal tubular necrosis in a rhesus monkey. , 1980, The Journal of infectious diseases.
[31] S. Malkiel,et al. Sarcomas induced by injection of simian virus 40 into neonatal CFW mice. , 1979, Journal of the National Cancer Institute.
[32] B. Eddy. SIMIAN VIRUS 40 (SV-40): AN ONCOGENIC VIRUS. , 1963, Progress in experimental tumor research.
[33] P. Gerber,et al. SV40-induced ependymomas in newborn hamsters. I. Virus-tumor relationships. , 1962, Virology.
[34] R. Kirschstein,et al. Papillary ependymomas produced in Rattus (Mastomys) natalensis inoculated with vacuolating virus (SV40). , 1962, Journal of the National Cancer Institute.
[35] B. Eddy,et al. Tumors Induced in Hamsters by Injection of Rhesus Monkey Kidney Cell Extracts , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.